ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
LabCorp at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
LabCorp brings 17 presentations to ASHG 2026 in Montréal, and exhibits at Booth 1024. Its ASHG 2026 program centres on rare disease, cancer, and clinical genetics, with applications in therapeutics and reproductive testing. Its presentations examine genomic testing in 1.8 million people and cancer biomarker disparities across ancestries, and its hosted session describes a Fabry disease phenotype found in real-world genomics data.
| Organization | ASHG 2026 Attendance |
|---|---|
LabCorp Burlington, North Carolina | 1 Lab Director · 1 Senior Applied Research Scientist in Oncology · 1 Data scientist · 1 Statistical Geneticist · 3 other presenters |
Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.
| Booth Exhibiting at Booth 1024 Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm Session Wed Oct 21 3:00 pm Poster Wed Oct 21 2:30 pm Diagnostic Yield and Clinical Utility of Genetic Testing in Unaffected Relatives with a Family History of Sudden Cardiac Death Genetic testingCardiovascular systemChannelopathiesClinical genetics Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Ancestry‑wide analysis of real‑world genomic testing reveals clinically relevant disparities in cancer prevalence, immunotherapy biomarkers, and variant actionabilityCancerClinical testingDiagnosticsEpidemiology Poster Wed Oct 21 2:30 pm Retrospective virtual panel modeling of carrier and high-risk couples detection by panel size in a large clinical reproductive carrier screening cohort Clinical testingGenetic counselingReproductive geneticsWomen's health Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Sex-driven gaps in guideline-concordant follow-up after population genomic screening for hereditary cancer, cardiovascular, and metabolic conditionsGenetic testingCancer syndromesGenetic epidemiologyPrecision medicine Poster Wed Oct 21 2:30 pm From global calibration to gene-aware evidence: calibrating pathogenicity predictions for real-world variant interpretation Artificial intelligenceVariant interpretationMethodologyGenetic testing Talk Thu Oct 22 8:15 am Closing the equity gap in variant classification: Machine learning-driven evidence demonstrates differential impact across race and ethnicity Computational toolsEthical, legal, and social implicationsGenetic testingMachine learning Talk Thu Oct 22 11:30 am Talk Thu Oct 22 2:15 pm Surveying the structural variant landscape in genetic testing: Prevalence and diagnostic yield in a clinical cohort of 1.8 million individuals Clinical geneticsCopy number/structural variationDiagnosticsGenetic testing Poster Thu Oct 22 4:15 pm ★ Reviewers’ Choice The impact of an iterative points-based framework on variant classification outcomes for neurodevelopmental disorders.Artificial intelligenceVariant interpretationNeurodevelopmentalClinical testing Poster Thu Oct 22 4:15 pm Applying Single Cell Transcriptomics and Machine Learning to Classify SCN1A Variants According to Disease Mechanism Laboratory genetics and genomicsGenomicsMachine learningGenetic variation Poster Thu Oct 22 4:15 pm A machine learning framework for accurate SMN1 copy number determination from short-read next-generation sequencing data BioinformaticsCopy number/structural variationGenomicsMachine learning Poster Thu Oct 22 4:15 pm Biochemical data and genetic testing: combining datasets to help classify variants Laboratory genetics and genomicsVariant interpretationPhenotypeMetabolic disorder Poster Fri Oct 23 2:30 pm Assessment of Structural and Copy Number Variants in Constitutional Samples Using Electronic Genome Mapping AneuploidyChromosomal abnormalitiesClinical testingCopy number/structural variation Poster Fri Oct 23 2:30 pm Validating gain- and loss-of-function multiplexed assay of variant effect (MAVE) predictions using linked genetic testing and biochemical datasets: a CASR case study Variant interpretationGenotype-phenotype correlationsMendelian disorderRare variants Poster Fri Oct 23 2:30 pm Evidence supporting RPS20 as a colorectal cancer susceptibility gene from a case-control study CancerCancer syndromesGenetic epidemiologyGenetic testing Poster Fri Oct 23 2:30 pm A conversational AI agent for multi-domain clinicogenomic research analytics with layered human-in-the-loop verification Artificial intelligenceComputational toolsDatabasesGenotype-phenotype correlations Poster Fri Oct 23 2:30 pm Single-cell transcriptomic variant effect mapping of clinically relevant MSH3 variants Machine learningMassively parallel sequencingVariant interpretation |
Find decision makers at LabCorp
Tell us what you sell and we’ll find the people at LabCorp most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction